Oxymetazoline Hydrochloride + D-PanthenolThird Party Manufacturing in India

Oxymetazoline Hydrochloride + D-Panthenol works through a dual therapeutic pathway where oxymetazoline causes vasoconstriction of the nasal arterioles while D-panthenol converts to pantothenic acid to support mucosal epithelial repair. It binds to alpha-adrenergic receptors to help the body lower mucosal swelling, while simultaneously hydrating the damaged tissue layer. Unlike standalone vasoconstrictor sprays that can cause excessive dryness or irritation, this combination maintains physiological hydration and protects mucosal integrity. It is highly effective and well-tolerated for congestion paired with tissue irritation.

Therapeutic Uses

• Congestion with Mucosal Dryness: Relieves nasal blockages while treating dry, cracked, or bleeding nasal membranes caused by cold weather or medication side effects.
• Rhinitis Sicca Management: Reduces vascular swelling while adding essential hydration to atrophic or crusting nasal layers.
• Post-infection Recovery: Restores damaged, irritated epithelial cells following prolonged viral upper respiratory infections.

Why Manufacturers Choose Oxymetazoline Hydrochloride + D-Panthenol

Oxymetazoline Hydrochloride + D-Panthenol third party manufacturing in India is an exceptionally popular B2B selection because it offers a premium, value-added upgrade over standard single-ingredient decongestants. It gives brands an advantage by directly addressing the common problem of rebound dryness found in standard sprays. Celesta manages high-grade production of this combination, verifying that our partner facilities are WHO-GMP certified to ensure precise ratio blending and uniform delivery.